CClinicalTrials.gg
CompletedNCT02330289ENLITenUpdated Apr 6, 2023

Effect of Norms on Laboratory and Imaging Testing (ENLITen)

An interventional study of Normative report card in Utilization and Laboratory, Hospital, sponsored by University of Pennsylvania. Completed. Per ClinicalTrials.gov, last updated 2023-04-06.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
154
Allocation
Randomized
Sex
All
01

Study summary

Studies suggest that some laboratory tests ordered for hospitalized patients are duplicative or have limited value. This study will evaluate a normative feedback intervention to reduce overuse of laboratory tests for hospitalized patients by internal medicine physicians-in-training.

Read the detailed description

Past research has shown that 25% of diagnostic testing is duplicative or has limited value. Academic medical centers that employ physicians-in-training may find it particularly challenging to reduce low value testing due to a historical emphasis on extensive workups by trainees. Despite the increased emphasis on cost-consciousness in medical education, there is little existing research evaluating ways to optimize ordering behaviors of physicians-in-training. This study will evaluate a normative feedback intervention for internal medicine physicians-in-training to reduce overuse of routine laboratory tests for hospitalized patients. Physicians-in-training will be cluster-randomized into two arms: (1) those who receive report cards (intervention group), (2) those who will not receive report cards (control group). We will study the use of routine laboratory tests over a pre-intervention period of 1 week and a post-randomization period of 1 week. We will study physician attitudes about the real-time feedback dashboard with qualitative assessments in focus groups after the completion of the intervention.

02

Conditions studied

  • Utilization
  • Laboratory, Hospital
03

In context

Lead sponsor

University of Pennsylvania is the lead sponsor of 1,635 studies on the registry; 239 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 104 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Any internal medicine physician-in-training scheduled to rotate through general medicine services at HUP during the study period will be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Physicians-in-training pulled for weekend coverage or sick coverage will be excluded. Medical students will be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
154 participants (actual)

Study arms

  • Experimental
    Report card arm

    The intervention arm will receive an email report card describing their lab use compared to their peers as well as a link to a website visually tracking the team's daily ordering of common lab tests compared to the peer teams.

    Behavioral: Normative report card

  • No intervention
    Control arm

    Physicians in the control arm will not receive the email or website link.

Interventions

  • BehavioralNormative report card

    Personalized visual report card describing physician's laboratory ordering pattern for prior week relative to peers as well as a link to a website tracking lab ordering for the team in real time compared to peer teams.

06

What researchers measure

Primary outcomes

  1. Routine laboratory tests/patient-day

    the number of routine laboratory tests per patient-day ordered by the physicians-in-training

    Time frame: 6 months

Secondary outcomes

  1. Laboratory costs

    Time frame: 6 months

  2. Routine imaging tests/patient-day

    Time frame: 6 months

  3. Physicians' attitudes toward laboratory test use and receiving feedback

    Focus groups

    Time frame: 6 months

Other outcomes

  1. Non-routine laboratory tests/patient-day

    Time frame: 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Ryskina K, Jessica Dine C, Gitelman Y, Leri D, Patel M, Kurtzman G, Lin LY, Epstein AJ. Effect of Social Comparison Feedback on Laboratory Test Ordering for Hospitalized Patients: A Randomized Controlled Trial. J Gen Intern Med. 2018 Oct;33(10):1639-1645. doi: 10.1007/s11606-018-4482-y. Epub 2018 May 22. PubMed 29790072 ↗
  • Kurtzman G, Dine J, Epstein A, Gitelman Y, Leri D, Patel MS, Ryskina K. Internal Medicine Resident Engagement with a Laboratory Utilization Dashboard: Mixed Methods Study. J Hosp Med. 2017 Sep;12(9):743-746. doi: 10.12788/jhm.2811. PubMed 28914280 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02330289
Lead sponsor
University of Pennsylvania
Responsible party
Kira Ryskina (Fellow, Division of General Internal Medicine, University of Pennsylvania) — Principal investigator
First posted
Jan 1, 2015
Start date
Dec 2015
Primary completion
Jun 2016
Completion
Sep 2016
Last update
Apr 6, 2023

Study contacts

Kira L Ryskina, MD
principal investigator · University of Pennsylvania

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion